In vivo models are essential tools for preclinical drug development, enabling researchers to assess the efficacy and safety of novel medications in a living organism. Identifying the appropriate organism is vital to confirm applicable preclinical results. This requires a meticulous understanding of the illness being studied, as well as the drawback